Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine.

De Abreu FB, Wells WA, Tsongalis GJ.

Am J Pathol. 2013 Oct;183(4):1075-83. doi: 10.1016/j.ajpath.2013.07.002. Epub 2013 Aug 3. Review.

2.

Personalized therapy for breast cancer.

De Abreu FB, Schwartz GN, Wells WA, Tsongalis GJ.

Clin Genet. 2014 Jul;86(1):62-7. doi: 10.1111/cge.12381. Epub 2014 Apr 9. Review.

PMID:
24635704
3.

Personalized oncology: recent advances and future challenges.

Kalia M.

Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19. Review.

PMID:
22999010
4.

Genetic heterogeneity in breast cancer: the road to personalized medicine?

Baird RD, Caldas C.

BMC Med. 2013 Jun 18;11:151. doi: 10.1186/1741-7015-11-151. Review.

5.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
7.

Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges.

Simpson PT, Vargas AC, Al-Ejeh F, Khanna KK, Chenevix-Trench G, Lakhani SR.

Hum Pathol. 2011 Feb;42(2):153-65. doi: 10.1016/j.humpath.2010.07.008. Epub 2010 Nov 24.

PMID:
21106225
8.

Molecular profiling: an essential technology enabling personalized medicine in breast cancer.

Liu J, Li S, Dunker AK, Uversky VN.

Curr Drug Targets. 2012 Apr;13(4):541-54. Review.

PMID:
22250651
9.

The changing role of pathology in breast cancer diagnosis and treatment.

Leong AS, Zhuang Z.

Pathobiology. 2011;78(2):99-114. doi: 10.1159/000292644. Epub 2011 Jun 14. Review.

10.

Personalized therapy for breast cancer: a dream or a reality?

Zardavas D, Pugliano L, Piccart M.

Future Oncol. 2013 Aug;9(8):1105-19. doi: 10.2217/fon.13.57.

PMID:
23902243
11.

Personalized medicine: present and future of breast cancer management.

Sabatier R, Gonçalves A, Bertucci F.

Crit Rev Oncol Hematol. 2014 Sep;91(3):223-33. doi: 10.1016/j.critrevonc.2014.03.002. Epub 2014 Mar 26. Review.

PMID:
24725667
12.

Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine.

Rivenbark AG, O'Connor SM, Coleman WB.

Am J Pathol. 2013 Oct;183(4):1113-24. doi: 10.1016/j.ajpath.2013.08.002. Epub 2013 Aug 27. Review.

13.

Molecular tests as prognostic factors in breast cancer.

van de Vijver MJ.

Virchows Arch. 2014 Mar;464(3):283-91. doi: 10.1007/s00428-014-1539-0. Epub 2014 Feb 1. Review.

PMID:
24487789
14.

Impact of the diagnostic methods on the therapeutic strategies.

Greco M, Agresti R, Giovanazzi R.

Q J Nucl Med. 1998 Mar;42(1):66-80. Review.

PMID:
9646647
15.

[Personalized medicine and breast cancer: anticipatory medicine, prognostic evaluation and therapeutic targeting].

Gonçalves A, Moretta J, Eisinger F, Bertucci F.

Bull Cancer. 2013 Dec;100(12):1295-310. doi: 10.1684/bdc.2013.1856. Review. French.

PMID:
24225763
16.

Breast cancer management: opportunities and barriers to an individualized approach.

Perez EA.

Oncologist. 2011;16 Suppl 1:20-2. doi: 10.1634/theoncologist.2011-S1-20.

17.
18.

Innovative biomarker development for personalized medicine in breast cancer care.

Zografos GC, Roukos DH.

Biomark Med. 2011 Feb;5(1):73-8. doi: 10.2217/bmm.10.116. No abstract available.

PMID:
21319967
19.

Breast cancer: new technologies for risk assessment and diagnosis.

Wright T, McGechan A.

Mol Diagn. 2003;7(1):49-55. Review.

PMID:
14529321
20.

Personalized medicine: the road ahead.

Mehta R, Jain RK, Badve S.

Clin Breast Cancer. 2011 Mar;11(1):20-6. doi: 10.3816/CBC.2011.n.004. Review.

PMID:
21421518
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk